Ineffectiveness of the presence of H-ras/p53 combination of mutations in squamous cell carcinoma cells to induce a conversion of a nontumorigenic to a tumorigenic phenotype.

作者: H. Lee , D. Li , T. Prior , B.C. Casto , C.M. Weghorst

DOI: 10.1023/A:1007419810705

关键词: Tumor suppressor genePhenotypeMolecular biologyEpidermoid carcinomaGeneMissense mutationBiologyCell cultureMutationTransfection

摘要: Human tumor cells have properties in vitro or surrogate hosts that are distinct from those of normal cells, such as immortality, anchorage independence, and formation nude mice. However, different individual tumors may exhibit some, but not all these features. In previous years, human cell lines derived tissue types been studied to determine molecular changes associated with the listed above tumorigenicity present study, seven were characterized for p53 ras mutations occur SCC phenotypes This investigation was designed examine whether co-occurrence mutated lead a malignant stage progression process. None contained recognized "hot spots" suppressor gene, four had nonsense/splice mutation codon 126 12 H-ras gene. The remaining three intron 5, 193, missense 126, respectively. Four nontumorigenic; two nonsense p53-126 ras; one at no fourth only 193. Two nontumorigenic converted after treatment methyl methanesulfonate N-methyl-N'-nitro-N-nitrosoguanidine apparent additional either Our analysis revealed there high frequency genetic diversity both H-ras. There also lack causal relationship presence cells' ability potential

参考文章(77)
George E. Milo, Hakjoo Lee, Molecular Control of Expression of Plasticity of Tumorigenic/Metastatic Phenotypes Humana Press, Totowa, NJ. pp. 223- 232 ,(1991) , 10.1007/978-1-4612-0411-4_23
Patricia Kahn, Graham Cameron, EMBL Data Library. Methods in Enzymology. ,vol. 183, pp. 23- 31 ,(1990) , 10.1016/0076-6879(90)83004-S
T Mitsudomi, Seth M Steinberg, Marion M Nau, David Carbone, Domenico D'Amico, Sara Bodner, Herbert K Oie, R Ilona Linnoila, James L Mulshine, John D Minna, None, p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene. ,vol. 7, pp. 171- 180 ,(1992)
Heiner Westphal, Yuji Yaginuma, Analysis of the p53 gene in human uterine carcinoma cell lines. Cancer Research. ,vol. 51, pp. 6506- 6509 ,(1991)
M S Greenblatt, W P Bennett, M Hollstein, C C Harris, Mutations in the p53 Tumor Suppressor Gene: Clues to Cancer Etiology and Molecular Pathogenesis Cancer Research. ,vol. 54, pp. 4855- 4878 ,(1994)
P. W. Hinds, S. J. Baker, C. A. Finlay, A. J. Levine, R. S. Quartin, B. Vogelstein, E. R. Fearon, Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the "hot spot" mutant phenotypes Cell Growth & Differentiation. ,vol. 1, pp. 571- 580 ,(1990)
Ettore Appella, Joseph R. Testa, Stephen Ullrich, William P. Bennett, Teresa A. Lehman, Curtis C. Harris, Judith A. Welsh, Rama V. Modali, Joseph W. Romano, Jill Ecker, Robert A. Metcalf, Brenda I. Gerwin, p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines. Cancer Research. ,vol. 51, pp. 4090- 4096 ,(1991)
Eric J. Stanbridge, Teresa A. Lehman, Alicia A. Briggs, Michael J. Anderson, Harris Shapiro, Jean-François Cajot, Growth Suppression Mediated by Transfection of p53 in Hut292DM Human Lung Cancer Cells Expressing Endogenous Wild-Type p53 Protein Cancer Research. ,vol. 52, pp. 6956- 6960 ,(1992)
M Fukayama, R Kikuchi-Yanoshita, Y Maeda, M Seki, M Konishi, T Mori, M Koike, H Iino, K Tanaka, S Ito, Genetic Changes of Both p53 Alleles Associated with the Conversion from Colorectal Adenoma to Early Carcinoma in Familial Adenomatous Polyposis and Non-Familial Adenomatous Polyposis Patients Cancer Research. ,vol. 52, pp. 3965- 3971 ,(1992)
Ranajit Chakraborty, C. T. Caskey, Y. Zhong, H. A. Hammond, Li Jin, Evaluation of 13 short tandem repeat loci for use in personal identification applications. American Journal of Human Genetics. ,vol. 55, pp. 175- 189 ,(1994)